S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

VYNE VYNE Therapeutics Inc

2.685

0.185 (7.40%)

Last Updated: 03:40:13

Delayed by 15 minutes

VYNE Therapeutics EPS beats by $0.08, misses on revenue

To read the full story on Seeking Alpha, click here.

VYNE Therapeutics (NASDAQ:VYNE)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more VYNE Therapeutics Charts.

VYNE Therapeutics (NASDAQ:VYNE)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more VYNE Therapeutics Charts.

VYNE Therapeutics Inc News

Form S-3 - Registration statement under Securities Act of 1933
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Saturday 3 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)

More VYNE Therapeutics Inc News Articles

S&P ASX 300 Metals and M...

Commonwealth Bank Of Aus...

Gold vs US Dollar

Woodside Petroleum

National Australia Bank

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions